Stem Cell Therapy for Early Alzheimer's Disease
Part of paid clinical trials in Houston, Texas.
- Sponsor
- Paul E Schulz
- Study ID
- NCT06775964
- Phase
- PHASE1/PHASE2
- Status
- Recruiting
Conditions
- Cognitive Dysfunction
Eligibility Criteria
- Sex
- ALL
- Age
- 60 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- adMSC — BIOLOGICALIV-infusion of autologous, adipose-derived, Mesenchymal Stem Cells (adMSCs), of approximately 2x10(8) adMSCs in 250mL saline.
Study Details
The goal of this clinical trial is to learn if stem cell therapy works to treat brain inflammation in adults. Inflammation in the brain may be involved in adults who have memory or thinking problems. The stem cells will be taken from participant's fat samples, processed and given back to participants, so they are their own donor. The main questions this trial aims to answer are: * Does stem cell therapy reduce inflammation in the brain? * Does stem cell therapy improve brain activity? * Does stem cell therapy slow down progression to Alzheimer's disease? Participants will: * Have a small fat biopsy taken at a doctor's office to process stem cells * Receive 4 infusions of stem cells, through a vein in the arm over 12 weeks * Visit the clinic every 2-4 weeks for the first 4 months and then every 1-2 months for 8 months for checkups and tests
Key Dates
- Start date
- Mar 11, 2026
- Status verified
- Apr 2026
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2028
Study Design
- Enrollment
- 12 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: adMSCIV-infusions of autologous, adipose-derived, Mesenchymal Stem Cells (adMSCs)
Primary Outcome Measure
Change in TSPO levels, measured by the PET scan, from baseline to midpoint and baseline to end of study [ Time Frame: Baseline, midpoint (169 days from 1st infusion) ]
Central Contacts
- Harshali Patel713-486-0531
- Javier Ortiz, PhD713-486-0505
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas Health Science Center at Houston (UTHealth) | Houston | Texas | 77054 |
Find similar trials in Houston, TX
Related Studies
- A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)PHASE2 · Not Yet Recruiting · Eli Lilly and Company · Chandler, Arizona
- PREsurgical Cognitive Evaluation Via Digital clockfacEdrawingRecruiting · University of Florida · Gainesville, Florida
- Strengthening Neuro-Cognitive Skills for Success in School, Work and BeyondRecruiting · VA Office of Research and Development · Sacramento, California
- Network-targeted Theta-burst Stimulation for Episodic Memory Improvement in Mild Cognitive ImpairmentRecruiting · University of California, Los Angeles · Los Angeles, California